1-10 of 10
Mignon L. Loh
Close
Sort by
Journal Articles

Identification of TCF3 germline variants in pediatric B-cell acute lymphoblastic leukemia

Carolin Escherich, Wenan Chen, Satoshi Miyamoto, Yui Namikawa, Wenjian Yang, David T. Teachey, Zhenhua Li, Elizabeth A. Raetz, Eric Larsen, Meenakshi Devidas, Paul L. Martin, W. Paul Bowman, Gang Wu, Ching-Hon Pui, Stephen P. Hunger, Mignon L. Loh, Masatoshi Takagi, Jun J. Yang
Journal: Blood Advances
Blood Adv (2023) 7 (10): 2177–2180.
https://doi.org/10.1182/bloodadvances.2022008563
Published: 2023
Includes: Supplemental data
Journal Articles

CD22 low /Bcl-2 high expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia

Clinical Trials & Observations
Astrid Wintering, Kenichi Ishiyama, Stanley Tamaki, Courtney Tamaki, Joshua Fandel, Lingyun Ji, Brent L. Wood, Nirali N. Shah, Constance M. Yuan, Maureen M. O’Brien, Mignon L. Loh, Ernesto Diaz-Flores
Journal: Blood Advances
Blood Adv (2023) 7 (2): 251–255.
https://doi.org/10.1182/bloodadvances.2021006810
Published: 2023
Includes: Supplemental data
Journal Articles

JMML tumor cells disrupt normal hematopoietic stem cells by imposing inflammatory stress through overproduction of IL-1β

Yuhan Yan, Lei Dong, Chao Chen, Kevin D. Bunting, Qianjin Li, Elliot Stieglitz, Mignon L. Loh, Cheng-Kui Qu
Journal: Blood Advances
Blood Adv (2022) 6 (1): 200–206.
https://doi.org/10.1182/bloodadvances.2021005089
Published: 2022
Includes: Supplemental data
Journal Articles

Simple and robust methylation test for risk stratification of patients with juvenile myelomonocytic leukemia

Hironobu Kitazawa, Yusuke Okuno, Hideki Muramatsu, Kosuke Aoki, Norihiro Murakami, Manabu Wakamatsu, Kyogo Suzuki, Kotaro Narita, Shinsuke Kataoka, Daisuke Ichikawa, Motoharu Hamada, Rieko Taniguchi, Nozomu Kawashima, Eri Nishikawa, Atsushi Narita, Nobuhiro Nishio, Asahito Hama, Mignon L. Loh, Elliot Stieglitz, Seiji Kojima, Yoshiyuki Takahashi
Journal: Blood Advances
Blood Adv (2021) 5 (24): 5507–5518.
https://doi.org/10.1182/bloodadvances.2021005080
Published: 2021
Includes: Supplemental data
Journal Articles

Juvenile myelomonocytic leukemia in the molecular era: a clinician’s guide to diagnosis, risk stratification, and treatment

Astrid Wintering, Christopher C. Dvorak, Elliot Stieglitz, Mignon L. Loh
Journal: Blood Advances
Blood Adv (2021) 5 (22): 4783–4793.
https://doi.org/10.1182/bloodadvances.2021005117
Published: 2021
Journal Articles

Nf1 and Sh2b3 mutations cooperate in vivo in a mouse model of juvenile myelomonocytic leukemia

Carolina E. Morales, Elliot Stieglitz, Scott C. Kogan, Mignon L. Loh, Benjamin S. Braun
Journal: Blood Advances
Blood Adv (2021) 5 (18): 3587–3591.
https://doi.org/10.1182/bloodadvances.2020003754
Published: 2021
Includes: Supplemental data
Journal Articles

Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphoma

Clinical Trials & Observations
Xinjie Xu, Christian N. Paxton, Robert J. Hayashi, Kimberly P. Dunsmore, Stuart S. Winter, Stephen P. Hunger, Naomi J. Winick, William L. Carroll, Mignon L. Loh, Meenakshi Devidas, Thomas G. Gross, Catherine M. Bollard, Sherrie L. Perkins, Rodney R. Miles
Journal: Blood Advances
Blood Adv (2021) 5 (14): 2890–2900.
https://doi.org/10.1182/bloodadvances.2021004334
Published: 2021
Includes: Supplemental data
Journal Articles

Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia

Clinical Trials & Observations
Anjali S. Advani, Eric Larsen, Kristina Laumann, Selina M. Luger, Michaela Liedtke, Meenakshi Devidas, Zhiguo Chen, Jun Yin, Matthew C. Foster, David Claxton, Kristin Coffan, Martin S. Tallman, Frederick R. Appelbaum, Harry Erba, Richard M. Stone, Stephen P. Hunger, Jennifer L. McNeer, Mignon L. Loh, Elizabeth Raetz, Naomi Winick, William Carroll, Richard A. Larson, Wendy Stock
Journal: Blood Advances
Blood Adv (2021) 5 (2): 504–512.
https://doi.org/10.1182/bloodadvances.2020002439
Published: 2021
Includes: Supplemental data
Journal Articles

Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemia

Clinical Trials & Observations
Thai Hoa Tran, Marian H. Harris, Jonathan V. Nguyen, Traci M. Blonquist, Kristen E. Stevenson, Eileen Stonerock, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Peter D. Cole, Kara M. Kelly, Caroline Laverdiere, Jean-Marie Leclerc, Bruno Michon, Marshall A. Schorin, Jennifer J. G. Welch, Shalini C. Reshmi, Donna S. Neuberg, Stephen E. Sallan, Mignon L. Loh, Lewis B. Silverman
Journal: Blood Advances
Blood Adv (2018) 2 (5): 529–533.
https://doi.org/10.1182/bloodadvances.2017014704
Published: 2018
Journal Articles

Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALL

Kathryn G. Roberts, Yung-Li Yang, Debbie Payne-Turner, Wenwei Lin, Jacob K. Files, Kirsten Dickerson, Zhaohui Gu, Jack Taunton, Laura J. Janke, Taosheng Chen, Mignon L. Loh, Stephen P. Hunger, Charles G. Mullighan
Journal: Blood Advances
Blood Adv (2017) 1 (20): 1657–1671.
https://doi.org/10.1182/bloodadvances.2017011296
Published: 2017
Includes: Supplemental data